CollPlant Biotechnologies

$7.72
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.20 (+2.64%) Today
-$0.06 (-0.77%) As of 9:51 PM UTC after-hours

Why Robinhood?

You can buy or sell CLGN and other stocks, options, and ETFs commission-free!

About CLGN

CollPlant Biotechnologies Ltd American Depositary Shares, also called CollPlant Biotechnologies, is a regenerative medicine company, which engages in the research, development, manufacture, and marketing of medical products for tissue repair such as bioprinting of tissues and organs, and medical aesthetics. The company's products include VergenixSTR, VergenixFG, and CollPlant Surgical Matrix. The company was founded by Oded Shoseyov in June 2004 and is headquartered in Rehovot, Israel. The listed name for CLGN is CollPlant Biotechnologies Ltd American Depositary Shares.

CEO
Yehiel Tal
Employees
46
Headquarters
Rehovot, Tel Aviv
Founded
2004
Market Cap
50.32M
Price-Earnings Ratio
Dividend Yield
Average Volume
36.53K
High Today
$7.89
Low Today
$7.25
Open Price
$7.50
Volume
20.79K
52 Week High
$14.55
52 Week Low
$4.77

Collections

CLGN Earnings

-$0.41
-$0.27
-$0.14
$0.00
Q1 FY19
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Estimated
per share
Actual
Expected Nov 27, Pre-Market

You May Also Like